Skip to main content
SpringerLink
Log in

Comparison of prenate advance™ with other prescription prenatal vitamins: a folic acid dissolution study

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Folic acid is important in the prevention of neural tube defects. This study assessed the folic acid dissolution performance of Prenate Advance and six other commonly prescribed prenatal vitamins and compared the results with the United States Pharmacopeia (USP) standards. Of the seven products tested, only three met the USP standard for folic acid dissolution. At 110% of the labeled amount, the Prenate Advance product had the highest folic acid dissolution level. Average dissolution for the four products failing to meet the USP standard ranged from 0% to 38% of labeled amount. These results corroborate findings from other studies suggesting marked differences in dissolution of prescription prenatal vitamins. These findings raise concerns of whether some women could fail to achieve the recommended folate levels needed in early pregnancy to prevent neural tube defects. Prenate Advance met the USP requirement for folic acid dissolution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. MRC Vitamin Study Research Group. Prevention of neural tube defects: result of the Medical Research Council Vitamin Study.Lancet. 1991;338:131–137.

    Article  Google Scholar 

  2. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects.MMWR. 1992;41(RR-14):1–7. Review.

  3. Food Standards: amendment of standards of identity for enriched grain products to require addition of folic acid.Federal Register. 1996;61(44):8781–8797.

    Google Scholar 

  4. March of Dimes.Folic Acid Fact Sheet. White Plains, NY; 1999.

    Google Scholar 

  5. Women of childbearing age still not consuming enough folic acid [press release]. Chicago, Ill: American Academy of Pediatrics; August 2,1999.

  6. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine.Dietary Reference Intakes: Thiamin, Riboflavin, Niacin,Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press; 1999.

    Google Scholar 

  7. Stout PJ, Brun J, Kenner J, et al. Performance assessment of vitamin supplements: efficacy issues.Pharm Res. 1996;13:S-71.

    Google Scholar 

  8. Hoag SW, Ramachandruni H, Shangraw RF. Failure of prescription prenatal vitamin products to meet USP standards for folic acid dissolution.J Am Pharm Assoc (Wash). 1997;37(4):397–400.

    Google Scholar 

  9. Pharmacopeia of the United States of America. 23rd ed. Supplement 4. Rockville, Md; US Pharmacopeial Convention; 1996.

  10. Sagraves R. Commentary: problems with folic acid dissolution—public health perspective.J Am Pharm Assoc (Wash). 1997;37(4):396.

Download references

Author information

Authors and Affiliations

  1. Celsis Laboratory Group, USA

    Ken Giebe B.S.

  2. Sanofi-Synthelabo Inc., USA

    Carl Counts B.S.

Authors
  1. Ken Giebe B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carl Counts B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giebe, K., Counts, C. Comparison of prenate advance™ with other prescription prenatal vitamins: a folic acid dissolution study. Adv Therapy 17, 179–183 (2000). https://doi.org/10.1007/BF02850293

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02850293

Keywords

Search

Navigation